Experts find druggable pocket in COVID-19, could lead to new antivirals
Category: #headlines  | By Nikita Chaurasia  | Date: 2020-09-23 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Experts find druggable pocket in COVID-19, could lead to new antivirals

An international team of scientists, which was led by the University of Bristol, has reportedly discovered a druggable pocket in SARS-CoV-2 (coronavirus) Spike protein which can potentially be utilized to prevent the virus from affecting human cells.

As per credible sources, the results can prove to be revolutionary in overcoming the pandemic since it can lead to new anti-viral drugs which target the druggable pocket in the virus.

The experts used electron cryo-microscopy (cryo-EM), a powerful imaging technique, to assess SARS-CoV-2 Spike at an atomic level, cited sources with knowledge of the matter. The team used Oracle Corporation’s cloud computing technology and developed a 3D structure of the virus in order to study its molecular structure.

If sources are to be believed, the research team have found linoleic acid (LA), a small molecule, concealed in a tailored pocket within the Spike protein, which is a free fatty acid and is not produced by the human body. In fact, linoleic acid plays an important role in immune modulation and inflammation, which are key aspects for coronavirus disease progression.

In this context, Christiane Schaffitzel, Professor from Bristol’s School of Biochemistry, was reported stating that researchers had previously discovered that tampering with LA metabolic pathways can result in acute respiratory distress syndrome, systemic inflammation and pneumonia. She added that these pathologies are found in patients with severe COVID-19 and a recent study of such patients has shown reduced levels of linoleic acid in their sera.

It is to be noted that a similar strategy was used for rhinovirus, a virus that leads to common cold. A similar pocket in the virus was used to produce potent small molecules which helped in distorting the structure and the infectivity of the rhinovirus.

In other news, leading firms including Moderna Inc., Johnson & Johnson, and Pfizer Inc., have reportedly pledged to not seek government approval before understanding the effectiveness of the COVID-19 vaccine.

Source- https://medicalxpress.com/news/2020-09-discovery-druggable-pocket-sars-cov-spike.html

https://www.deseret.com/u-s-world/2020/9/7/21424213/coronavirus-covid-19-vaccine-pfizer-johnson-johnson-moderna

 

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Shell trades off Russian retail business to native oil producer Lukoil

Shell trades off Russian retail business to native oil producer Lukoil

By Nikita Chaurasia

Energy giant Shell plans on selling more than 400 petrol stations of its Russian subsidiary Shell Neft to Lukoil, the second largest oil producer in the country after state backed Rosneft. As several Western oil and gas firms seek to get rid of th...

Mitsubishi, Siemens sign an MoU to cooperate in SiC traction technology

Mitsubishi, Siemens sign an MoU to cooperate in SiC traction technology

By Nikita Chaurasia

Mitsubishi Electric Europe and Siemens Mobility have recently signed a memorandum of understanding (MoU) to work together in silicon carbide (SiC) traction power technology. As per reports, JR Central’s next-generation N700S Shinkansen train...

Legato opens 80 new jobs in its Limerick Research & Development hub

Legato opens 80 new jobs in its Limerick Research & Development hub

By Nikita Chaurasia

The global capability center of a leading U.S. health care insurance company, Legato Health Technologies is planning to build an additional 80 posts at its Limerick facility. It would bring the total number of staff to 200, which the fir...